Morgellons in Dogs: What the 2016 Study Found—and What It Still Cannot Prove

Editor’s note — August 2, 2026: This page was originally published on December 28, 2016, and reproduced a PRWeb release describing Morgellons disease in dogs as “scientifically proven.” That language exceeded the conclusions of the underlying study. The original article has been replaced with the evidence review below so that the journal, funding, case selection and laboratory methods can be evaluated alongside the findings. During this revision, I did not locate a verifiable archived copy of the former page; the original PRWeb release remains publicly available.

Can Dogs Get Morgellons Disease?

Morgellons disease is not an established veterinary diagnosis. A 2016 case series nevertheless described nine dogs with chronic skin lesions containing embedded or projecting filaments and proposed that the condition was analogous to human Morgellons disease.

The observation deserves investigation. Dogs cannot form or communicate a human belief that fibers are emerging from their bodies, so an animal model challenges explanations based entirely on mistaken belief.

The paper did not independently establish that these dogs had Lyme disease. Three dogs underwent conventional Lyme serology and tested negative, while testing was explicitly listed as “Not performed” for the other six. The Lyme attribution instead depended primarily on staining, culture and PCR findings obtained from the affected skin.

Table of Contents

1. Read the Paper, Not Just the Press Release
2. The Investigators’ Case
3. What Were the Nine Dogs Like?
4. Were the Filaments Biologically Characterized?
5. No Dog Had Reported Positive Conventional Lyme Serology
6. What Did the Culture Experiments Show?
7. What Did the PCR and Sequencing Establish?
8. What Controls Were Reported?
9. Licking, Oral Spirochetes and Assay Specificity
10. What Does “Five Independent Laboratories” Mean?
11. Venue, Funding and Disclosure
12. How Were the Cases Selected?
13. Dogs Remove the Delusion Explanation—but Not Self-Trauma
14. Why the Lyme Claim Is Both Unusual and Potentially Important
15. What Does Bovine Digital Dermatitis Add?
16. Has the Canine Finding Been Independently Replicated?
17. What Would Resolve the Question?
18. What Should Dog Owners Do?
19. Author Clarification and Dated Updates
20. The Evidence in Perspective

Read the Paper, Not Just the Press Release

The paper, Canine Filamentous Dermatitis Associated with Borrelia Infection, was authored by Marianne Middelveen, Gheorghe Rotaru, Jody McMurray, Katherine Filush, Eva Sapi, Jennie Burke, Agustin Franco, Lorenzo Malquori, Melissa McElroy and Raphael Stricker.

The full text is freely downloadable through the University of New Haven repository. The article is licensed under Creative Commons Attribution 4.0, allowing its figures to be reproduced with proper attribution.

The paper appeared in the Journal of Veterinary Science & Medical Diagnosis in October 2016. It was received on September 12, accepted on September 28 and published on October 3.

Its conclusion was cautious: the authors wrote that a filamentous dermatitis analogous to Morgellons disease may be a manifestation of canine Lyme disease. The accompanying press release converted that into the headline “Morgellons Disease Scientifically Proven to Occur in Dogs,” described the journal as “prestigious,” and stated that the animal findings confirmed the disease was not a delusion.

Those were promotional conclusions, not findings established by the study design.

The Investigators’ Case

Presented in its strongest form, the authors’ argument had several connected parts.

They reported filaments embedded in or projecting from chronic canine lesions rather than merely loose material collected from the coat. In Dog C1, some sectioned filaments stained as collagen or mixed collagen and keratin. Other specimens showed cellular or abnormal hair-like structures. The investigators also reported spirochete-like forms using silver staining and immunostaining, followed by positive Borrelia-targeted PCR results from every dog’s tissue, culture or both.

Two amplicons were sequenced and reported as 99 percent matches to Borrelia burgdorferi sensu stricto. Testing was distributed among five facilities using several gene targets and laboratory methods. All four asymptomatic control dogs were PCR-negative in the direct specimens tested. The authors also reported improvement in several dogs after antibiotic-containing treatment regimens, including relapse after antibiotics were discontinued in one case.

The investigators interpreted these findings as a coherent pattern: biologically derived filaments, spirochetal evidence, Borrelia-targeted molecular signals and reported treatment responses occurring together in affected dogs but not in the small control group. They argued that the pattern supported a canine filamentous dermatitis analogous to human Morgellons disease and potentially associated with Lyme borreliosis.

That is the affirmative case. The remaining question is whether the design excluded competing explanations adequately.

What Were the Nine Dogs Like?

The study included three English Bulldogs, two Miniature Schnauzers, a Golden Retriever, a Chihuahua, a Beagle–Pug cross and a dog described as a “Bullie.”

Six dogs lived in Alberta, Canada. The other three lived in Colorado, Texas and Kentucky. Their ages ranged from approximately seven months to nearly eight years.

Dermatological findings

• Painful or pruritic ulcers
• Crusted lesions on the back and sides
• Lesions on the head or between the toes
• Hair loss and abnormal hair texture
• Nodules and welts
• Perianal or genital inflammation
• Secondary bacterial infection

Several dogs had previously received diagnoses such as atopic dermatitis, allergic dermatitis, staphylococcal infection or demodicosis.

Other reported signs

Some case histories also mentioned fatigue, behavioral changes or lameness. Lameness is relevant because joint disease is a recognized manifestation of canine Lyme borreliosis, but it was not accompanied by positive conventional Lyme serology in this series.

The dogs had received different combinations of antibiotics, steroids, antifungal agents, topical cyclosporine, antipruritic medication and antiseptic treatments. The authors reported improvement following antibiotic-containing regimens in several cases.

Those responses are difficult to interpret. Antibiotics can improve secondary bacterial infections, while steroids and topical treatments can reduce inflammation and itching. Because multiple therapies were often given together, the case histories cannot demonstrate that treatment directed at Borrelia resolved a Borrelia-caused filamentous dermatitis.

Were the Filaments Biologically Characterized?

The filaments were initially identified through direct examination with a handheld 50× microscope, examination of removed material at 50× or greater magnification and, in some cases, histological sections.

The authors described white, pink, blue, purple or teal filaments measuring approximately 10–40 micrometers in diameter. Some reportedly fluoresced under ultraviolet illumination.

Color, shape and fluorescence cannot establish that a filament was produced by the skin. The paper did, however, perform more specific characterization in a limited number of specimens.

Dog C1: Collagen and keratin staining

Dog C1 provided the strongest evidence of biological filament composition.

Sectioned filaments were examined using Gömöri trichrome staining. Some stained green, which the authors interpreted as collagen. Others stained green and red, interpreted as containing both collagen and keratin.

The filaments were also described as having a hollow medulla and solid cortex resembling structures reported in the authors’ human Morgellons publications.

Dog C5: A nucleated shaft

A filament from Dog C5 was described as having visible nuclei concentrated toward its point of origin. The authors interpreted this as evidence that it was a cellular structure rather than a textile fiber.

A red-staining spiral form attached to the shaft was interpreted as a spirochete following polyclonal anti-Borrelia immunostaining. The antibody was not species-specific, and the authors acknowledged that it could cross-react with other organisms.

Dogs C3 and C4: Abnormal hairs

Coarse black structures from Dogs C3 and C4 showed scaling and follicular anatomy consistent with hairs. The authors described malformed or fused follicular bulbs and multiple hair shafts arising together.

These findings support an abnormal biological hair origin, but they do not establish that those hairs represented the same process as the collagen-containing filaments in Dog C1.

The canine analogy therefore rests on more than loose fibers viewed under a handheld microscope. At least one dog had filaments chemically characterized as collagen or mixed collagen and keratin, while other specimens showed cellular or hair-like anatomy.

But composition was not established consistently across all nine dogs. The paper generalized from a small number of characterized specimens to a proposed canine syndrome.

For a broader explanation of how tissue-associated filaments differ from surface contamination, see the Morgellons fibers evidence review.

No Dog Had Reported Positive Conventional Lyme Serology

The dog identifiers require one clarification before the results are listed: Dog C6 is the study’s label for its sixth canine subject. It should not be confused with the B. burgdorferi C6 peptide detected by the SNAP 4Dx Lyme antibody assay.

Table 1 reports:

• Dog C1: IFA and SNAP 4Dx negative
• Dog C3: SNAP 4Dx negative
• Dog C6: SNAP 4Dx negative
• Dogs C2, C4, C5, C7, C8 and C9: testing “Not performed”

The absence of testing in six dogs is stated explicitly rather than inferred from blank cells. Three dogs were tested and negative, six were not tested, and none had reported positive conventional Lyme serology.

Negative serology cannot exclude every infection. Test timing, immune response, previous antibiotic treatment and assay performance can affect results. The untested dogs, however, cannot be counted as negative, positive or serologically supported Lyme cases.

The investigators instead placed greater weight on tick-exposure histories, lesion microscopy, staining, culture and PCR. This creates an internally dependent argument: the evidence used to identify Lyme disease came primarily from the same disputed skin specimens the proposed infection was intended to explain.

The study may have detected infections that serology missed. It may instead have detected incidental, introduced or false-positive molecular material. Its design could not distinguish those possibilities securely.

“Skin lesions containing Borrelia-targeted molecular signals” is therefore better supported than “a manifestation of canine Lyme disease.”

What Did the Culture Experiments Show?

Dermatological tissue was inoculated into BSK-H medium containing rabbit serum, phosphomycin, rifampicin and amphotericin B. Cultures were incubated under microaerophilic conditions at 32°C, examined weekly by dark-field microscopy for four weeks and then processed for staining or PCR.

The paper reports culture specimens from six dogs:

• Dog C1
• Dog C2
• Dog C4
• Dog C7
• Dog C8
• Dog C9

All six reported culture specimens produced at least one positive PCR result.

This is properly described as six positive results among the six cultures reported in the paper. The paper does not state whether additional cultures were attempted and remained negative.

The reported specimen pattern was:

• Direct-tissue and culture positivity reported: Dogs C1 and C2
• Direct-tissue positivity reported without a culture result: Dogs C3, C5 and C6
• Only culture-derived positivity reported: Dogs C4, C7, C8 and C9

The final category does not establish that direct tissue was negative. Table 5 summarizes positive findings and does not state whether direct tissue from those four dogs was tested and negative, not submitted or not tested.

The authors’ favorable interpretation

Culture can enrich viable organisms that are initially present below an assay’s detection threshold. On that interpretation, the culture-derived results support the possibility that low-abundance Borrelia organisms multiplied until they became detectable.

This interpretation deserves particular consideration because only culture-derived positivity was reported for four dogs. The pattern is compatible with culture increasing the concentration of a genuinely lesion-derived organism.

The unresolved culture-control problem

The same uniform culture pattern could also occur if target organisms or DNA entered through shared medium, reagents or downstream culture processing.

The paper reports water controls, extraction blanks, negative tissues and PCR controls. It does not report an uninoculated BSK-H tube carried through the full four-week incubation, dark-field examination, centrifugation, extraction and PCR process.

The selectivity of BSK-H does not resolve this issue. Its antimicrobial components affect organism survival and growth; PCR can detect target DNA whether or not the source organism grew successfully.

A full-process medium control was therefore needed to distinguish genuine culture enrichment from contamination introduced during the culture pathway.

Half the sequence evidence came from a culture specimen

The paper’s two sequenced findings were obtained from different specimen types:

• Dog C3: direct dermatological tissue, pyrG
• Dog C7: dermatological culture, 16S

Marianne Middelveen confirmed in an August 5, 2026, email that Dog C7’s positive PCR result and sequenced amplicon were derived from culture, as indicated in Table 5.

She also explained why the specimen sources differed. Dog C3 was located in Colorado and was geographically inaccessible for culture, while Dog C7 was located in Calgary, where culture could be performed. This provides an ordinary logistical explanation for the different specimen types and does not suggest that culture was selectively chosen because direct-tissue testing had failed.

An earlier draft of this review described the results narrative as contradicting Table 5. That characterization was incorrect and has been retracted.

The paper states that “dermatological specimens” submitted for PCR included both dermatological tissue and DNA extracted from skin-culture pellets. The term was therefore being used as an umbrella category rather than as a synonym for uncultured tissue.

The remaining issue is reporting clarity rather than internal contradiction. The abstract, narrative and conclusion do not consistently distinguish direct-tissue findings from culture-derived findings when summarizing the molecular evidence. Table 5 is required to determine that Dog C7’s sequence came from culture.

A culture-derived sequence demonstrates that matching DNA was present in the tested culture. Without a full-process negative culture control or independent repeat culture, it provides less secure evidence that the organism originated in the original lesion at a clinically meaningful concentration.

The culture arm had no negative canine comparator

The study included four asymptomatic control dogs, but Middelveen clarified that none underwent culture.

• Control Dogs 1 and 2 provided dander and hair.
• Control Dogs 3 and 4 provided skin biopsies.
• No skin cultures were performed for any control dog.

The culture arm therefore contained six reported canine specimens, all six of which produced culture-derived PCR positivity, but no cultured specimen from a healthy control dog.

This does not determine why all six cultures were positive. Culture may have enriched viable, low-abundance Borrelia genuinely present in the affected specimens. But the study lacked a negative canine culture comparator showing how the same process behaved when applied to specimens from dogs without the proposed condition.

The original clarification request separately asked whether an uninoculated BSK-H tube was incubated for four weeks and then carried through centrifugation, extraction and PCR. Middelveen’s August 5 response described the control-dog specimens but did not directly answer that medium-only-control question.

A follow-up was sent asking specifically whether an uninoculated BSK-H tube completed the full culture pipeline. Until that question is answered, the appropriate conclusion is that a full-process medium control is not reported in the paper or confirmed in the correspondence received to date—not that such a control was definitively never performed.

What Did the PCR and Sequencing Establish?

The study used assays targeting 16S ribosomal RNA, OspC, BB0006, pyrG and rpoC. These assays did not all have identical validation or evidentiary value.

The 139-base-pair assay

The University of New Haven used a 139-base-pair Borrelia 16S real-time PCR assay developed in prior work by O’Rourke and collaborators.

The earlier validation study reported:

• Detection of 83 diverse B. burgdorferi sensu lato strains
• No amplification from the 21 unrelated microbial species tested
• A lower limit of detection of six target copies per reaction

A six-copy detection limit is a genuine strength when searching for low-abundance organisms in tissue. It is also sensitive enough to detect trace carryover, making rigorous extraction, batch and full-process controls especially important. Sensitivity increases both the assay’s ability to find scarce targets and its vulnerability to very small contamination events.

The validation was external to the canine-study author group, but it was not commercially neutral. The work was funded by Baxter Bioscience; several authors were Baxter employees, and two authors disclosed a patent connected to a Lyme-vaccine program. Those interests were disclosed in the original validation paper.

This does not erase the analytical validation. It places it in the same disclosure framework applied to Australian Biologics’ commercial role in the canine study.

The external validation also supports only this particular 139-base-pair assay. It does not automatically validate every nested, endpoint or real-time PCR method used by the other participating laboratories.

The O’Rourke assay paper can be read in PLOS ONE.

The two sequenced findings

Only two dogs produced amplicons that were sequenced:

• Dog C3: pyrG, reported as a 99 percent match to B. burgdorferi sensu stricto strain B31
• Dog C7: 16S, reported as a 99 percent match to the same strain and confirmed by Middelveen to have come from culture

The other seven dogs were classified through assay-level signals without comparable sequence confirmation.

The PDF shows forward and reverse alignments but provides no GenBank accession numbers, downloadable canine sequence files or raw Sanger chromatograms. The paper states that chromatograms were analyzed, but readers cannot examine those chromatograms or retrieve deposited canine sequences independently.

Middelveen stated that the forward and reverse sequences supplied by Eva Sapi’s laboratory are included in the paper and referred further questions about the University of New Haven methods and results to Sapi. Sapi was contacted directly to ask whether the sequences were deposited in a public repository and whether raw sequence files or chromatograms are available.

What Controls Were Reported?

The molecular methods included legitimate safeguards.

At the University of New Haven, real-time PCR reactions were performed in triplicate with a B31 positive control and water negative controls. Additional negative tissues were tested without reported detection.

Australian Biologics reported positive and negative controls, eluted water as an extraction blank and an internal extraction control.

Mount Allison University reported multiple negative controls, separate work areas for extraction, PCR preparation and gel electrophoresis, and newly designed primers intended to reduce carryover from earlier amplicons.

The four asymptomatic control dogs were negative by the PCR assays performed on their direct specimens. Middelveen later clarified that no cultures were performed on the control dogs.

The methods do not report:

• Blinding of laboratory personnel to case status
• Random distribution of cases and controls across extraction batches
• Batch-specific extraction blanks for every laboratory run
• An uninoculated medium control carried through the complete culture process
• A cultured specimen from an asymptomatic control dog
• Independent re-extraction and confirmation from untouched tissue
• External confirmation by investigators outside the collaborating network

A control dog, extraction blank, no-template PCR tube and uninoculated culture tube address different potential errors. They are not interchangeable.

Licking, Oral Spirochetes and Assay Specificity

Dogs frequently lick itchy, painful and ulcerated skin. A primary 2024 metagenomic study by Alessandri and colleagues analyzed canine saliva and dental plaque from 30 healthy dogs, 18 dogs with chronic gingival inflammation and 18 dogs with periodontitis.

The researchers identified Treponema among the more abundant bacterial genera in saliva and dental plaque from healthy dogs. They also found that Treponema medium was significantly more abundant in saliva from dogs with chronic gingival inflammation than in healthy dogs.

Full citation: Alessandri G, Fontana F, Mancabelli L, et al. Species-level characterization of saliva and dental plaque microbiota reveals putative bacterial and functional biomarkers of periodontal diseases in dogs. FEMS Microbiology Ecology. 2024;100(6):fiae082. doi:10.1093/femsec/fiae082.

Licking therefore provides a plausible route by which oral spirochetes or spirochetal DNA could enter an already ulcerated lesion.

Whether this matters depends on the specificity of the finding:

• Dieterle staining identifies spirochetal morphology but not species.
• Dark-field microscopy can demonstrate motile spiral forms but cannot establish species identity.
• The polyclonal anti-Borrelia antibody had acknowledged cross-reactivity.
• Molecular assays not validated against canine oral spirochetes leave more room for alternative interpretation.
• The previously validated 139-base-pair Borrelia assay is less readily explained by ordinary oral Treponema DNA.

The oral-spirochete hypothesis does not explain away Dog C3’s direct-tissue pyrG sequence reported as matching B. burgdorferi sensu stricto. That remains the strongest individual molecular result in the paper.

It should also not be used as the primary explanation for the cases with only culture-derived positivity reported. Because Table 5 does not establish that those dogs were direct-tissue negative, the published pattern cannot show that oral or environmental DNA was absent before culture.

The central culture question remains whether target material genuinely originating in each canine specimen was enriched during incubation or entered during culture and downstream processing.

What Does “Five Independent Laboratories” Mean?

Testing was distributed across five separate facilities:

• Heartland Veterinary Clinic
• McClain Laboratories
• University of New Haven
• Australian Biologics
• Mount Allison University

This allowed clinical examination, pathology, staining, culture and molecular testing to occur in different locations.

It did not constitute five independent replications.

The facilities were components of one coordinated project. Authors or collaborators selected or received the cases, performed different parts of the analysis and interpreted the combined findings. Five unaffiliated groups did not receive blinded specimens and independently reproduce the same result.

Several authors also belonged to the overlapping research network responsible for much of the literature proposing an association between human Morgellons disease and borrelial infection.

In her August 5 response, Middelveen emphasized that multiple collaborating laboratories used various methodologies and produced results the investigators regarded as convergent. That is a legitimate description of internal convergence across the project. It is not equivalent to independent replication by investigators outside the network.

The accurate description is that testing was distributed among five facilities participating in one collaborative study.

Venue, Funding and Disclosure

Publishing venue, affiliations and funding do not decide whether an observation is true. They indicate how much independent scrutiny and disclosure surrounded the claim before it was promoted publicly.

The journal

The Journal of Veterinary Science & Medical Diagnosis is a SciTechnol publication. As verified in the National Library of Medicine catalog on August 2, 2026, its NLM ID is 101608650, and its status was “not currently indexed for MEDLINE.” Selected citations may appear in PubMed when individual manuscripts are deposited through public-access pathways; that is not journal-wide MEDLINE indexing.

The catalog entry is available through the National Library of Medicine.

Librarian Jeffrey Beall reported in 2012 that SciTechnol had been created as an OMICS-associated publishing brand encompassing dozens of journals. I did not verify that this particular veterinary title was individually named in Beall’s preserved list, so the narrower statement is appropriate: it was a SciTechnol journal, and SciTechnol was reported as an OMICS-created imprint.

SciTechnol was not a named defendant in the later Federal Trade Commission case, and the canine article was not individually evaluated by the court.

In 2019, a federal court entered a $50.1 million judgment against OMICS Group, iMedPub, Conference Series and their owner over deceptive representations concerning peer review, editorial boards, indexing and publishing charges. The canine paper’s sixteen-day submission-to-acceptance period does not establish what review occurred. Given the surrounding publishing history, however, the journal name alone cannot serve as evidence that a rigorous external filter was applied.

Open-access funding

The paper states that funding for open-access publication was provided by the Charles E. Holman Morgellons Disease Foundation of Austin, Texas.

That disclosure concerns the publication charge. It should not be expanded into a claim that the foundation paid for all specimen collection, laboratory work or investigator time.

It remains relevant that a Morgellons advocacy foundation paid the open-access charge for a paper supporting a Morgellons-like canine condition and subsequently issued a press release announcing that the condition had been scientifically proven.

Competing interests

The paper includes author affiliations, acknowledgments, funding information and an author-contributions section.

It does not contain a labeled competing-interests or conflicts-of-interest declaration. The ILADS and Australian Biologics affiliations were visible in the byline, but the paper did not discuss whether any organizational, advocacy, clinical or commercial relationships were considered potential competing interests.

How Were the Cases Selected?

The dogs were not identified through a prospective survey of all chronic canine lesions seen at multiple veterinary dermatology practices.

Six cases arose through Heartland Veterinary Clinic in Alberta after veterinarians familiar with the human Morgellons literature noticed lesions they considered similar and contacted the other researchers. Additional cases entered through owner or veterinarian referrals.

The owners of Dogs C3, C5 and C6 were reported to have lesions diagnosed as Morgellons disease and prior knowledge of the condition. The owners of the other six dogs reportedly had no prior Morgellons knowledge.

Those six owners are an important counterweight to the claim that every case resulted from an owner imposing a personal diagnosis on a pet.

The referral process still selected for the expected pattern. Owners and veterinarians familiar with Morgellons were more likely to search for microscopic filaments, interpret them as unusual and send specimens to investigators already studying that hypothesis.

This case-ascertainment pathway prevents the nine dogs from representing the prevalence or typical presentation of canine dermatological disease.

Dogs Remove the Delusion Explanation—but Not Self-Trauma

A dog cannot hold a human verbalized delusion that fibers are emerging from its skin. If a biological filament is demonstrated within canine tissue, the dog’s belief cannot explain it.

Dogs can still produce severe lesions through persistent licking, chewing and scratching.

Acral lick dermatitis is a recognized canine condition in which repeated licking produces chronic thickening, inflammation, secondary infection and ulceration. Several dogs in the study were intensely pruritic, and some had prior allergic, parasitic or bacterial diagnoses.

Damaged skin in a hair-bearing animal is exposed to broken hairs, follicular material, saliva, bedding, bandages, carpet fibers, crust and wound debris.

The canine model therefore removes the delusional-belief arm of the alternative explanation. It does not remove the self-trauma, oral-inoculation and contamination arm.

That alternative was not established in these nine dogs. The study did not include a blinded comparison group of dogs with acral lick dermatitis, severe atopic disease or similarly ulcerated wounds examined through the same microscopy, staining, culture and molecular protocol.

The infectious interpretation and its principal alternative both remain incompletely tested.

Why the Lyme Claim Is Both Unusual and Potentially Important

The principal recognized manifestations of canine Lyme borreliosis are joint disease and a less common renal syndrome. Dermatological manifestations analogous to human Lyme disease are considered rare and poorly documented in dogs.

That makes filamentous dermatitis an extraordinary extension of the accepted clinical spectrum. It requires strong evidence, especially when none of the nine dogs had reported positive conventional serology.

It would also matter if reproduced. A genuine Borrelia-associated canine filamentous dermatitis could expand veterinary understanding of borreliosis and provide a model for examining how infection might alter keratin, collagen or hair production.

The unconventional nature of the claim increases both its evidentiary burden and its potential significance.

What Does Bovine Digital Dermatitis Add?

The authors connected the canine cases to bovine digital dermatitis, an independently established cattle disease strongly associated with multiple Treponema phylotypes.

Bovine digital dermatitis demonstrates that spirochetes can participate in painful, proliferative and ulcerative animal skin disease. That gives investigators a biological reason to study other proposed spirochete-associated dermatoses.

It does not establish that bovine digital dermatitis, canine filamentous dermatitis and human Morgellons disease are the same process. “Morgellons-like” is a proposed analogy, not the standard veterinary classification of the cattle disease.

The bovine evidence establishes plausibility, not canine causation.

Has the Canine Finding Been Independently Replicated?

For this revision, I searched PubMed and Google Scholar on August 2, 2026, using the exact paper title and the terms “canine filamentous dermatitis,” “Morgellons-like dermatitis dogs” and “Morgellons in dogs.”

I did not identify an independently authored study reproducing the finding in a separate canine cohort. Later reviews citing the cases were largely written by members of the same overlapping Morgellons research network.

This is not the same as a failed replication. Veterinary dermatology does not appear to have conducted a systematic prospective study looking for tissue-embedded filaments in chronic canine lesions using blinded pathology, composition testing and contamination-controlled molecular methods.

Unreplicated because refuted and unreplicated because untested are different states. The canine hypothesis remains largely untested outside the original research group.

What Would Resolve the Question?

A stronger study would prospectively recruit dogs from ordinary veterinary dermatology practices before anyone classified their lesions as Morgellons-like.

It would compare proposed cases with dogs having acral lick dermatitis, atopic disease, infected or ulcerated lesions, Lyme seropositivity without skin disease and no dermatological disease.

Pathologists would examine coded biopsies without knowing clinical or PCR status. Cases and controls would be distributed across the same extraction batches. Uninoculated culture medium, extraction blanks and no-template controls would pass through the complete process.

Positive findings would be reproduced from untouched tissue and confirmed by an unaffiliated laboratory. Oral samples would help determine whether lesion-associated spirochetes matched organisms in the same dog’s mouth. Sequences, accession numbers and chromatograms would be made public.

The essential questions are:

1. Are biological filaments embedded in the proposed lesions more often than in ordinary chronic canine wounds?
2. Is Borrelia reproducibly present under blinded, contamination-controlled conditions?
3. Is it located within tissue in a pattern capable of explaining filament formation?

The 2016 study raised these questions but did not answer them conclusively.

What Should Dog Owners Do?

Loose fibers around a dog’s wound cannot diagnose Morgellons disease. Hair, bedding fibers, bandage material, saliva, crust and environmental debris commonly adhere to inflamed or moist skin.

Persistent ulcers, draining lesions, severe itching, abnormal hair growth or apparently embedded material should be evaluated by a veterinarian. Testing may include cytology, skin scrapings, bacterial or fungal culture, parasite testing and biopsy.

A biopsy examined by a veterinary pathologist is more informative than fibers pulled from the coat because it preserves the relationship between the structure and living tissue.

Lyme testing may be appropriate when tick exposure and clinical findings justify it, but serology documents exposure rather than proving that Borrelia caused a particular lesion.

Owners should avoid digging into lesions or applying harsh chemicals to extract material. Doing so can worsen trauma, introduce infection and destroy evidence needed for useful examination.

Author Clarification and Dated Updates

The Evidence in Perspective

The affirmative case has meaningful components. The authors reported filaments within canine lesions, collagen and keratin staining in Dog C1, cellular or abnormal hair structures in other specimens, positive results from several Borrelia-targeted assays, six reported PCR-positive cultures, negative direct specimens from control dogs, two sequence-level matches and clinical improvement after antibiotic-containing regimens. Middelveen also emphasized that several facilities using different methods produced findings the investigators regarded as convergent.

The Lyme interpretation remains uncertain. No dog had positive conventional serology; six dogs were explicitly listed as not tested; only culture-derived positivity was reported for four dogs; none of the control dogs underwent culture; no full-process culture-medium control has yet been documented; most cases lacked sequence confirmation; and no unaffiliated group has reproduced the findings.

Morgellons-like filamentous dermatitis has been reported in dogs, but its relationship to Borrelia and canine Lyme disease remains unproven. The finding warrants independent testing—not dismissal and not promotion as established fact.

---

Source Notes

The PDF prints a DOI ending in 1000217, while the University of New Haven repository and publisher metadata use 1000212. The repository renders the foundation’s name as “Charles E. Hollman,” whereas the article PDF and the organization use Charles E. Holman Morgellons Disease Foundation.